Evidence map›Paper›PMID 35215852›Full record

ArticleViruses2022

Epidemiology and Genetic Analysis of SARS-CoV-2 in Myanmar during the Community Outbreaks in 2020.

Wint Wint Phyu, Reiko Saito, Keita Wagatsuma, Takashi Abe, Htay Htay Tin, Eh Htoo Pe, Su Mon Kyaw Win, Nay Chi Win, Lasham Di Ja, Sekizuka Tsuyoshi and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Wint Wint PhyuDivision of International Health (Public Health), Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.ORCID 0000-0002-7208-830X
Reiko SaitoDivision of International Health (Public Health), Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.ORCID 0000-0002-1554-8226
Keita WagatsumaDivision of International Health (Public Health), Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.
Takashi AbeDivision of Bioinformatics, Graduate School of Science and Technology, Niigata University, Niigata 950-2181, Japan.
Htay Htay TinNational Health Laboratory, Department of Medical Services, Dagon Township, Yangon 111-91, Myanmar.
Eh Htoo PeNational Health Laboratory, Department of Medical Services, Dagon Township, Yangon 111-91, Myanmar.
Su Mon Kyaw WinInfectious Diseases Research Center of Niigata University in Myanmar (IDRC), Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.
Nay Chi WinInfectious Diseases Research Center of Niigata University in Myanmar (IDRC), Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.
Lasham Di JaInfectious Diseases Research Center of Niigata University in Myanmar (IDRC), Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.
Sekizuka TsuyoshiPathogen Genomics Center, National Institute of Infectious Diseases, Tokyo 189-0002, Japan.
Kuroda MakotoPathogen Genomics Center, National Institute of Infectious Diseases, Tokyo 189-0002, Japan.
Yadanar KyawRespiratory Medicine Department, Thingangyun Sanpya General Hospital, Yangon 110-71, Myanmar.
Irina ChonDivision of International Health (Public Health), Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.
Shinji WatanabeInfluenza and Other Respiratory Virus Research Center, National Institute of Infectious Diseases, Tokyo 189-0002, Japan.
Hideki HasegawaInfluenza and Other Respiratory Virus Research Center, National Institute of Infectious Diseases, Tokyo 189-0002, Japan.
Hisami WatanabeInfectious Diseases Research Center of Niigata University in Myanmar (IDRC), Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.

Funding

Japan Program for Infectious Diseases Research and Infrastructure 20wm0125010h0001, ED20wm0125010h0001, and 20wm0225002h0001
6 · The paper itself

Abstract

We aimed to analyze the situation of the first two epidemic waves in Myanmar using the publicly available daily situation of COVID-19 and whole-genome sequencing data of SARS-CoV-2. From March 23 to December 31, 2020, there were 33,917 confirmed cases and 741 deaths in Myanmar (case fatality rate of 2.18%). The first wave in Myanmar from March to July was linked to overseas travel, and then a second wave started from Rakhine State, a western border state, leading to the second wave spreading countrywide in Myanmar from August to December 2020. The estimated effective reproductive number (

Indexed as

AdultAgedChildCommunity-Acquired InfectionsCOVID-19EpidemicsFemaleGenome, ViralHumansMaleMiddle AgedMutationMyanmarPhylogenyPublic HealthSARS-CoV-2case fatality ratecommunity transmissionCOVID-19molecular epidemiologyreproductive numberSARS-CoV-2whole-genome sequences

Identifiers

PMID35215852
PMCPMC8875553

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.